Pembrolizumab-induced necrotizing myositis in a patient with metastatic non-small-cell lung cancer: a case report
{{output}}
A 57-year-old man presented with swelling and pain in the lower limbs, inability to walk and increasing dyspnea for 2 days. Because of refractory stage IV non-small-cell lung cancer, pembrolizumab was started 21 days before presentation. Since then, he experie... ...